Eton Pharmaceuticals (ETON)
(Delayed Data from NSDQ)
$3.12 USD
-0.09 (-2.80%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $3.12 0.00 (0.00%) 4:42 PM ET
3-Hold of 5 3
B Value A Growth F Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -0.02 |
EPS Last Quarter | -0.09 |
Last EPS Surprise | -125.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.26 |
Next Year | NA |
EPS (TTM) | -0.03 |
P/E (F1) | 12.35 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 8.30M | 10.00M | 41.40M | NA |
# of Estimates | 1 | 1 | 1 | NA |
High Estimate | 8.30M | 10.00M | 41.40M | NA |
Low Estimate | 8.30M | 10.00M | 41.40M | NA |
Year ago Sales | 5.30M | 12.00M | 31.64M | 41.40M |
Year over Year Growth Est. | 56.60% | -16.67% | 30.84% | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.02 | 0.07 | 0.26 | NA |
# of Estimates | 1 | 1 | 1 | NA |
Most Recent Consensus | -0.02 | 0.07 | 0.26 | NA |
High Estimate | -0.02 | 0.07 | 0.26 | NA |
Low Estimate | -0.02 | 0.07 | 0.26 | NA |
Year ago EPS | -0.10 | 0.18 | -0.04 | 0.26 |
Year over Year Growth Est. | 80.00% | -61.11% | 750.00% | NA |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | NA |
Up Last 30 Days | 0 | 0 | 0 | NA |
Up Last 60 Days | 0 | 0 | 0 | NA |
Down Last 7 Days | 0 | 0 | 0 | NA |
Down Last 30 Days | 0 | 0 | 0 | NA |
Down Last 60 Days | 0 | 0 | 0 | NA |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.02 | 0.07 | 0.26 | NA |
7 Days Ago | -0.02 | 0.07 | 0.26 | NA |
30 Days Ago | -0.02 | 0.07 | 0.26 | NA |
60 Days Ago | -0.02 | 0.07 | 0.26 | NA |
90 Days Ago | -0.02 | 0.07 | 0.26 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.02 | 0.07 | 0.26 | NA |
Zacks Consensus Estimate | -0.02 | 0.07 | 0.26 | NA |
Earnings ESP | 0.00% | 0.00% | 0.00% | NA |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.09 | -0.02 | 0.18 | -0.10 | NA |
Estimate | -0.04 | -0.10 | -0.09 | -0.14 | NA |
Difference | -0.05 | 0.08 | 0.27 | 0.04 | 0.09 |
Surprise | -125.00% | 80.00% | 300.00% | 28.57% | 70.89% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more